The PBM Accountability Project recently joined several pharmacy, employer, and consumer advocates to encourage the new administration and 119th Congress to prioritize meaningful PBM reforms to help lower prescription drug costs for Americans.
As the letters explain, bipartisan reforms that advanced through both chambers last year, “address anti-competitive, anti-consumer practices employed by PBMs,” and leaders have an opportunity to “deliver relief to patients and families at their local pharmacies, employers facing continued increases in healthcare costs, and taxpayers who are currently overpaying for government-provided benefit programs,” by advancing these bills.